Related references
Note: Only part of the references are listed.Real-Time PCR Confirmation of a Fatal Case of Primary Amoebic Meningoencephalitis in Turkey Caused by Naegleria fowleri or Brain-Eating Amoeba
Koray Oncel et al.
ACTA PARASITOLOGICA (2022)
Deoxyvasicinone with Anti-Melanogenic Activity from Marine-Derived Streptomyces sp. CNQ-617
Se-eun Lee et al.
MARINE DRUGS (2022)
Identification of Leucinostatins from Ophiocordyceps sp. as Antiparasitic Agents against Trypanosoma cruzi
Jean A. Bernatchez et al.
ACS OMEGA (2022)
Cyclolauranes as plausible chemical scaffold against Naegleria fowleri
Inigo Arberas-Jimenez et al.
BIOMEDICINE & PHARMACOTHERAPY (2022)
Development of a Machine Learning-Based Cysticidal Assay and Identification of an Amebicidal and Cysticidal Marine Microbial Metabolite against Acanthamoeba
Brian Shing et al.
MICROBIOLOGY SPECTRUM (2022)
Epidemiology and Clinical Characteristics of Primary Amebic Meningoencephalitis Caused by Naegleria fowleri: A Global Review
Radhika Gharpure et al.
CLINICAL INFECTIOUS DISEASES (2021)
New perspectives in oral peptide delivery
Alessandra T. Zizzari et al.
DRUG DISCOVERY TODAY (2021)
Defueling the cancer: ATP synthase as an emerging target in cancer therapy
Ting Wang et al.
MOLECULAR THERAPY-ONCOLYTICS (2021)
Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro
Jose Ignacio Escrig et al.
ACS CHEMICAL NEUROSCIENCE (2020)
Marine microbial natural products: the evolution of a new field of science
William (Bill) Fenical
JOURNAL OF ANTIBIOTICS (2020)
Laurinterol from Laurencia johnstonii eliminates Naegleria fowleri triggering PCD by inhibition of ATPases
Inigo Arberas-Jimenez et al.
SCIENTIFIC REPORTS (2020)
Natural products and other inhibitors of F1FO ATP synthase
Bhargav A. Patel et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Bioactivity of Farnesyltransferase Inhibitors Against Entamoeba histolytica and Schistosoma mansoni
Alexandra Probst et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2019)
Marine-Derived Anticancer Agents: Clinical Benefits, Innovative Mechanisms, and New Targets
Renato B. Pereira et al.
MARINE DRUGS (2019)
Staurosporine from Streptomyces sanyensis activates Programmed Cell Death in Acanthamoeba via the mitochondrial pathway and presents low in vitro cytotoxicity levels in a macrophage cell line
Luis Cartuche et al.
SCIENTIFIC REPORTS (2019)
The therapeutic strategies against Naegleria fowleri
Natalia Karla Bellini et al.
EXPERIMENTAL PARASITOLOGY (2018)
Verification of oligomycin A structure: synthesis and biological evaluation of 33-dehydrooligomycin A
Lyudmila N. Lysenkova et al.
JOURNAL OF ANTIBIOTICS (2017)
CYP51 is an essential drug target for the treatment of primary amoebic meningoencephalitis (PAM)
Anjan Debnath et al.
PLoS Neglected Tropical Diseases (2017)
Biology and pathogenesis of Naegleria fowleri
Ruqaiyyah Siddiqui et al.
ACTA TROPICA (2016)
The unique chemistry and biology of the piericidins
Xuefeng Zhou et al.
JOURNAL OF ANTIBIOTICS (2016)
Naegleria fowleri after 50 years: is it a neglected pathogen?
Moises Martinez-Castillo et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2016)
Natural Products as Sources of New Drugs from 1981 to 2014
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2016)
The marine actinomycete genus Salinispora: a model organism for secondary metabolite discovery
Paul R. Jensen et al.
NATURAL PRODUCT REPORTS (2015)
Diagnosis, Clinical Course, and Treatment of Primary Amoebic Meningoencephalitis in the United States, 1937-2013
Linda G. Capewell et al.
JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2015)
Synthesis and cytotoxicity of oligomycin A derivatives modified in the side chain
Lyudmila N. Lysenkova et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2013)
Natural Products as a Source for Treating Neglected Parasitic Diseases
Dieudonne Ndjonka et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
A novel acyclic oligomycin A derivative formed via retro-aldol rearrangement of oligomycin A
Lyudmila N. Lysenkova et al.
JOURNAL OF ANTIBIOTICS (2012)
Natural Products As Sources of New Drugs over the 30 Years from 1981 to 2010
David J. Newman et al.
JOURNAL OF NATURAL PRODUCTS (2012)
Medicinal Plants: A Source of Anti-Parasitic Secondary Metabolites
Michael Wink
MOLECULES (2012)
Pathogenic Naegleria fowleri and non-pathogenic Naegleria lovaniensis exhibit differential adhesion to, and invasion of, extracellular matrix proteins
Melissa Jamerson et al.
MICROBIOLOGY-SGM (2012)
Amebic meningoencephalitides and keratitis: challenges in diagnosis and treatment
Govinda S. Visvesvara
CURRENT OPINION IN INFECTIOUS DISEASES (2010)
The epidemiology of primary amoebic meningoencephalitis in the USA, 1962-2008
J. S. Yoder et al.
EPIDEMIOLOGY AND INFECTION (2010)
In vitro and in vivo antitrypanosomal activities of three peptide antibiotics: leucinostatin A and B, alamethicin I and tsushimycin
Aki Ishiyama et al.
JOURNAL OF ANTIBIOTICS (2009)
Amphotericin B: side effects and toxicity
Rafael Laniado-Laborin et al.
REVISTA IBEROAMERICANA DE MICOLOGIA (2009)
ATP Synthase and the Actions of Inhibitors Utilized To Study Its Roles in Human Health, Disease, and Other Scientific Areas
Sangjin Hong et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2008)
The immune response to Naegleria fowleri amebae and pathogenesis of infection
Francine Marciano-Cabral et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2007)
Developing a new resource for drug discovery: marine actinomycete bacteria
William Fenical et al.
NATURE CHEMICAL BIOLOGY (2006)
Natural products as antiparasitic drugs
O Kayser et al.
PARASITOLOGY RESEARCH (2003)